A comparative study of two different doses of cytarabine for acute myeloid leukemia: a phase III trial of Cancer and Leukemia Group B. [electronic resource]
Producer: 19921016Description: 2520-6 p. digitalISSN:- 0006-4971
- Acute Disease
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cytarabine -- administration & dosage
- Daunorubicin -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Follow-Up Studies
- Humans
- Leukemia, Myeloid -- drug therapy
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Remission Induction
- Thioguanine -- administration & dosage
- Time Factors
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.